These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 3740398)

  • 21. Low R-wave amplitude in the right precordial leads in children with symptomatic doxorubicin cardiomyopathy.
    Umemoto M; Azuma E; Itoh M; Komada Y; Ido M; Kawasaki H; Kita H; Sakurai M
    Pediatr Cardiol; 1993 Mar; 14(2):107-9. PubMed ID: 8385775
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The feature of cardial remodeling process at Doxorubicin chemotherapy and idiopathic dilatative cardiomyopathy].
    Katamadze NA; Lartsuliani KP; Begishvili NN; Dundua KhV; Kiknadze MP
    Georgian Med News; 2006 Jan; (130):61-4. PubMed ID: 16510915
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Dilated cardiomyopathy post-chemotherapy].
    Sbrana F; Greco P; Rovai D
    Recenti Prog Med; 2009 Mar; 100(3):132-6. PubMed ID: 19475840
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular mechanisms of heart muscle disease.
    Lewis W; Papoian T
    West J Med; 1991 Jan; 154(1):91. PubMed ID: 2024517
    [No Abstract]   [Full Text] [Related]  

  • 25. Atrophic nerve fibers in regions of reduced MIBG uptake in doxorubicin cardiomyopathy.
    Takano H; Ozawa H; Kobayashi I; Hamaoka S; Nakajima A; Nakamura T; Naitoh A; Koizumi K; Tamura K
    J Nucl Med; 1995 Nov; 36(11):2060-1. PubMed ID: 7472599
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adriamycin: review of clinical pharmacology and toxicity of an effective anticancer drug.
    Riggs CE; Sharp SA
    Iowa Med; 1987 May; 77(5):242, 245-51. PubMed ID: 3298138
    [No Abstract]   [Full Text] [Related]  

  • 27. A canine model of dilated cardiomyopathy induced by repetitive intracoronary doxorubicin administration.
    Toyoda Y; Okada M; Kashem MA
    J Thorac Cardiovasc Surg; 1998 Jun; 115(6):1367-73. PubMed ID: 9628680
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Doxorubicin administration by continuous infusion is not cardioprotective: the Dana-Farber 91-01 Acute Lymphoblastic Leukemia protocol.
    Lipshultz SE; Giantris AL; Lipsitz SR; Kimball Dalton V; Asselin BL; Barr RD; Clavell LA; Hurwitz CA; Moghrabi A; Samson Y; Schorin MA; Gelber RD; Sallan SE; Colan SD
    J Clin Oncol; 2002 Mar; 20(6):1677-82. PubMed ID: 11896119
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Doxorubicin induces senescence and impairs function of human cardiac progenitor cells.
    Piegari E; De Angelis A; Cappetta D; Russo R; Esposito G; Costantino S; Graiani G; Frati C; Prezioso L; Berrino L; Urbanek K; Quaini F; Rossi F
    Basic Res Cardiol; 2013 Mar; 108(2):334. PubMed ID: 23411815
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The effect of the anthracycline derivative doxorubicin on myocardial function in children].
    Sobotka-Plojhar MA; Daniëls O; Rohmer J; Veerman AJ; Lippens R; van Lier H
    Ned Tijdschr Geneeskd; 1989 Jul; 133(27):1367-70. PubMed ID: 2797225
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [A case of irreversible cardiomyopathy induced by polychemotherapy].
    Skopets IS; Vezikova NN; Ivanova EP; Sergeeva SS; Ignatenko OV
    Ter Arkh; 2015; 87(12):73-76. PubMed ID: 26978422
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Developing a rat model of dilated cardiomyopathy with improved survival.
    Shen LJ; Lu S; Zhou YH; Li L; Xing QM; Xu YL
    J Zhejiang Univ Sci B; 2016 Dec.; 17(12):975-983. PubMed ID: 27921402
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fatal pulmonary hypertension after heart transplantation: sequelae of postactinic pulmonary vascular changes.
    Niederhäuser U; Vogt P; Schneider J; Schmid ER; Tornic M; Gasser C; Oechslin E; Turina MI
    J Thorac Cardiovasc Surg; 1995 Nov; 110(5):1565-6. PubMed ID: 7475210
    [No Abstract]   [Full Text] [Related]  

  • 34. The last to die is hope: prolonged mechanical circulatory support with a Novacor left ventricular assist device as a bridge to transplantation.
    Casarotto D; Bottio T; Gambino A; Testolin L; Gerosa G
    J Thorac Cardiovasc Surg; 2003 Feb; 125(2):417-8. PubMed ID: 12579117
    [No Abstract]   [Full Text] [Related]  

  • 35. [Nail pigmentation during therapy with cyclophosphamide and doxorubicin].
    Manigand G; Faux N; Dumas D; Taillandier J; Fixy P; Richerd F
    Sem Hop; 1983 Jun; 59(24):1840-1. PubMed ID: 6136095
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Protective effect of Spirulina against doxorubicin-induced cardiotoxicity.
    Khan M; Shobha JC; Mohan IK; Naidu MU; Sundaram C; Singh S; Kuppusamy P; Kutala VK
    Phytother Res; 2005 Dec; 19(12):1030-7. PubMed ID: 16372368
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Doxorubicin induced dilated cardiomyopathy in a rabbit model: an update.
    Gava FN; Zacché E; Ortiz EM; Champion T; Bandarra MB; Vasconcelos RO; Barbosa JC; Camacho AA
    Res Vet Sci; 2013 Feb; 94(1):115-21. PubMed ID: 22902286
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Successful long-term course after heart transplantation for anthracycline cardiomyopathy in a young boy despite neurological complications.
    Deng MC; Kececioglu D; Weyand M; Moskopp D; Fahrenkamp A; Wendt M; Scheld HH
    Thorac Cardiovasc Surg; 1994 Apr; 42(2):122-4. PubMed ID: 8016827
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Recurrence of dilated cardiomyopathy after re-introduction of a tricyclic antidepressant.
    Briec F; Delaire C; Bouhour JB; Trochu JN
    Arch Mal Coeur Vaiss; 2006 Oct; 99(10):933-5. PubMed ID: 17100146
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Pediatric Hodgkin disease in North Tunisia: clinical and therapeutic study].
    Kochbati L; Fdhila F; Belaid I; Rifi H; Barsaoui S; Ben Romdhane N; Bel Hadj Ali Z; Mezlini A; Oubich F; Maalej M
    Cancer Radiother; 2012 Oct; 16(7):627-32. PubMed ID: 23084987
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.